Innovation is inevitable in any industry, and the field of medical marijuana is no different. With laws already in the books in 18 states and more on the way, investors who might not know their Blue Chips from their Blue Dream are flocking to these regions to stake their claim in what they see as the next big commodity.
White-collar Wall Street-types can certainly see the budding upside to sinking money into dispensaries, growing operations, and other cannabis related retail outlets. But those potential gains are often outweighed by the prospects of inventory control, employee management, product naiveté. And of course, the grey area that exists in all current state-level medical marijuana laws that fly in the face of Federal statute. Cue MedBox.